We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$992B
AUM Growth
-$120B
Cap. Flow
-$16.9B
Cap. Flow %
-1.7%
Top 10 Hldgs %
27.94%
Holding
3,085
New
108
Increased
1,637
Reduced
1,059
Closed
107

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.45B
2
JPM icon
JPMorgan Chase
JPM
+$2.22B
3
TEAM icon
Atlassian
TEAM
+$2.08B
4
NVDA icon
NVIDIA
NVDA
+$1.81B
5
AAPL icon
Apple
AAPL
+$1.67B

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Healthcare 17.19%
3 Consumer Discretionary 15.16%
4 Financials 10.74%
5 Communication Services 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LZ icon
651
LegalZoom.com
LZ
$993M
$127M 0.01%
8,988,235
-2,408,244
-21% -$36.2M
VRTS icon
652
Virtus Investment Partners
VRTS
$1.14B
$127M 0.01%
528,995
+7,045
+1% +$1.78M
POOL icon
653
Pool Corp
POOL
$7.29B
$127M 0.01%
299,552
-36,126
-11% -$16.9M
JXN icon
654
Jackson Financial
JXN
$9.1B
$126M 0.01%
2,850,276
-368,792
-11% -$15.4M
RDN icon
655
Radian Group
RDN
$4.92B
$126M 0.01%
5,662,034
+1,850
+0% +$42.6K
NEX
656
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$126M 0.01%
13,582,535
-3,691,360
-21% -$26.4M
AGCO icon
657
AGCO
AGCO
$6.96B
$125M 0.01%
857,916
-53,050
-6% -$6.7M
PAR icon
658
PAR Technology
PAR
$770M
$125M 0.01%
3,096,775
+61,734
+2% +$2.53M
NWE icon
659
NorthWestern Energy
NWE
$4.4B
$124M 0.01%
2,052,280
-781,356
-28% -$45.7M
ATRC icon
660
AtriCure
ATRC
$2.21B
$124M 0.01%
1,884,271
-61,480
-3% -$3.98M
SKY icon
661
Champion Homes
SKY
$5.23B
$124M 0.01%
2,252,973
+299,345
+15% +$20.3M
USPH icon
662
US Physical Therapy
USPH
$1.24B
$124M 0.01%
1,242,637
+3,605
+0.3% +$344K
HLI icon
663
Houlihan Lokey
HLI
$9.24B
$123M 0.01%
1,398,417
+2,059
+0.1% +$212K
BMRN icon
664
BioMarin Pharmaceuticals
BMRN
$13.3B
$123M 0.01%
1,589,345
+370,312
+30% +$31M
PRAA icon
665
PRA Group
PRAA
$762M
$122M 0.01%
2,711,618
+10,949
+0.4% +$506K
APO icon
666
Apollo Global Management
APO
$84.8B
$122M 0.01%
1,967,437
+742,770
+61% +$48.9M
AMBP icon
667
Ardagh Metal Packaging
AMBP
$3.16B
$121M 0.01%
14,891,763
+255,261
+2% +$2.21M
PLTK icon
668
Playtika
PLTK
$961M
$121M 0.01%
6,261,098
-2,658,306
-30% -$47.3M
ROCK icon
669
Gibraltar Industries
ROCK
$1.45B
$121M 0.01%
2,811,089
-225,529
-7% -$11.9M
DCT
670
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$121M 0.01%
5,453,649
+14,013
+0.3% +$335K
ACAD icon
671
Acadia Pharmaceuticals
ACAD
$4.89B
$121M 0.01%
4,978,936
-4,507,325
-48% -$109M
TTEK icon
672
Tetra Tech
TTEK
$9.33B
$121M 0.01%
3,655,330
+51,775
+1% +$1.59M
MATX icon
673
Matsons
MATX
$6.39B
$120M 0.01%
997,168
-1,081,546
-52% -$109M
AZZ icon
674
AZZ Inc
AZZ
$4.52B
$119M 0.01%
2,475,926
-7,833
-0.3% -$388K
ALG icon
675
Alamo Group
ALG
$1.99B
$119M 0.01%
827,773
+63,732
+8% +$9.23M

Similar funds

T. Rowe Price Associates's Q1 2022 Portfolio in Review

As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
  • T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
  • T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
  • T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
  • T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
  • T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.